News

One Stop Systems Welcomes New CFO – A Step Forward in Leadership

One Stop Systems Welcomes New CFO – A Step Forward in Leadership

Leadership Transition at One Stop Systems

One Stop Systems, Inc. (NASDAQ: OSS), a leading provider of rugged computing solutions for artificial intelligence (AI) and machine learning (ML) applications, is embarking on a pivotal leadership change. This comes as the company announces the appointment of Daniel Gabel as the new Chief Financial Officer (CFO). Gabel will succeed John Morrison, who has been with OSS since September 2017 and is set to retire soon.

The Journey of Change

Effective November 11, 2024, Gabel will officially take on the roles of CFO, Treasurer, and Secretary, marking the beginning of a new chapter for the company. As Morrison steps back, he will stay on for a brief period to ensure a smooth transition, allowing Gabel to step confidently into his new role.

Messages of Gratitude and Anticipation

In a statement, Mike Knowles, the CEO of OSS, expressed his gratitude for Morrison's dedication over the years. He remarked on Morrison's integral role in shaping the financial strategies that have propelled OSS forward. “His expertise has greatly influenced our growth and direction,” Knowles stated, adding, “We wish him all the best in his future endeavors.”

Introducing Daniel Gabel

Daniel Gabel arrives with an impressive track record in the defense industry, bringing over 14 years of financial leadership experience to OSS. Prior to this, he served as the CFO of CAES’ Defense System Division, which operates under Honeywell and provides high-end electronic solutions for aerospace and defense clients. Gabel’s career also includes more than a decade at RTX Corporation (Raytheon), where he held various financial roles, ultimately serving as CFO of SEAKR Engineering from 2021 to 2023.

OSS’s Expansion and Future Growth

The transition to Gabel as CFO reflects a strategic pivot for OSS, aligning with the company's growth ambitions across both commercial and defense markets. Gabel's experience aligns perfectly with OSS's current aspirations for expansion into high-growth areas within the edge computing market.

Focused on AI Transportables

One Stop Systems specializes in AI Transportable solutions that meet the rigorous demands of edge computing environments. Their range of products includes rugged servers, compute accelerators, flash storage arrays, and software designed for accelerated storage. These solutions cater to various industries including autonomous vehicles, defense, and industrial applications.

Commitment to High Standards

OSS’s solutions are designed to manage the entire AI workflow, enhancing performance in demanding scenarios. With cutting-edge technology that combines high-speed data acquisition with deep learning capabilities, OSS is dedicated to delivering unparalleled value to its clients.

Building a Competitive Edge

The edge computing market continues to expand dramatically, and OSS is well-positioned to capitalize on these opportunities. By appointing Gabel, OSS reinforces its commitment to operational excellence and aims to enhance shareholder value through innovative financial strategies and robust leadership.

As OSS continues to navigate through these transitions, the focus remains on leveraging comprehensive technological advancements while maintaining rigorous performance standards. OSS is committed to making a significant impact across dynamic industries, ensuring that they remain at the forefront of the AI Transportable market.

Frequently Asked Questions

Who is the new CFO of One Stop Systems?

Daniel Gabel has been appointed as the new Chief Financial Officer of One Stop Systems, succeeding John Morrison.

When will the leadership transition take place?

The transition will be effective November 11, 2024, with Morrison providing support until November 30, 2024.

What experience does Daniel Gabel bring to OSS?

Gabel has over 14 years of experience in the finance sector, particularly within the defense industry, having served as CFO at CAES and other key roles at RTX Corporation.

What does One Stop Systems specialize in?

OSS specializes in rugged computing solutions for AI, ML, and sensor processing applications, particularly in challenging environments.

How does OSS address the AI workflow?

OSS solutions manage the full AI workflow, incorporating high-speed data acquisition, deep learning, and large-scale inference capabilities for optimal performances.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Class Action Greenlighted Against Concordia for Title IX Violations

Updated Category News Views 87

Paving the Way for Equality in Campus Sports Ah, courts and colleges—two institutions you'd hope would play by the rules. But here we are, knee-deep in a legal battle with Concordia University Irvine (CUI) caught in the crosshairs of Title IX compliance issues. No surprise there when a federal court finally gave the nod for a class action to plow ahead. Class Action...

Continue Reading
AppLovin Legal Woes: A Deep Dive into Investor Claims

Updated Category News Views 104

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...

Continue Reading
Microsoft's Cloud Misstep: Recovery Plans in Focus

Updated Category News Views 149

Microsoft's Stumble Puts CIOs on Alert Thursday's Microsoft 365 outage, a wrench in the works for every firm that ties its daily operations to these cloud services, has brought some harsh truths to the table. On November 12, outages hit users hard, preventing access to Exchange Online mailboxes and sending ripples through Teams, SharePoint, Copilot, and Defender. You...

Continue Reading
EFICYENT Ventures to Connect at Singapore FinTech Fest

Updated Category News Views 118

Why the Singapore FinTech Festival Matters The world's hardly a stranger to hype, but the Singapore FinTech Festival carries some real weight. From November 18 to 20, 2026, this gig isn't just industry chatter—it's a high-stakes convergence of policymakers, financial institutions, fintech innovators like EFICYENT, and the money folk looking to mold the future of...

Continue Reading
Innovent's Seven Drugs Leap onto 2026 Reimbursement Chart

Updated Category News Views 202

A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 162

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 179

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
Maritime Safety Urged After New Orleans Vessel Incident

Updated Category News Views 109

The Mississippi River saw a bit of drama near the Port of New Orleans when a river cruise turned into an unexpected rescue operation. Listen up, because incidents like this bring maritime safety right to the forefront; we can't ignore the waters that shape our daily lives here in the Big Easy. Navigating the Waters Safely Some 150 souls found themselves in a pickle when...

Continue Reading
Windward Bio Surges 68% in Nasdaq Debut

Updated Category News Views 134

Windward Bio's Impressive Nasdaq Debut Well, how's that for a debut? Windward Bio, this buzzing clinical-stage biotechnology firm, hit Nasdaq like a storm on November 13, 2026. They priced their IPO at $17.00 per share, but by market close, the stock sat comfortably at $28.50. That's a hearty 68% jump on day one, putting their market value at a sweet $1.69 billion. Behind...

Continue Reading
Ecopetrol Sidesteps Hefty Fines After Investigation Closure

Updated Category News Views 145

Colombian Watchdog Gives Ecopetrol a Pass It's like dodging a bullet in a duel at high noon. The Superintendency of Industry and Commerce (SIC) has finally closed its investigation into Ecopetrol S.A. and its subsidiaries, CENIT and OCENSA, after a probe two years in the making. The stakes were sky-high, folks. We're talkin' about just shy of 530 billion Colombian pesos...

Continue Reading

Top 5 Most Recently Viewed Articles

Kimbell Royalty Partners Engages Investors at Key Conferences

Updated Category News Views 101

Kimbell Royalty Partners to Attend Notable Investor Conferences Kimbell Royalty Partners, LP (NYSE: KRP) is a prominent owner of oil and natural gas mineral and royalty interests. The company proudly manages over 129,000 gross wells across multiple states. In an effort to strengthen investor relations and share its strategic outlook, Kimbell has announced its...

Continue Reading
Karsan's Autonomous Bus Debuts at Efteling Park

Updated Category News Views 72

A Leap Towards Autonomous Mobility What we have here is Karsan breaking new ground again. They've rolled out their Autonomous e-ATAK at Efteling, the famous theme park in the Netherlands. And that's not just any park—it's a place teeming with tourists, a hotspot demanding efficient transport. Yet, these folks aren't just cranking out fancy gadgets for showing off....

Continue Reading
EyePoint Pharmaceuticals Expands Workforce with Stock Options

Updated Category News Views 301

EyePoint Pharmaceuticals Expands Workforce with Stock Options EyePoint Pharmaceuticals, Inc. (Nasdaq: EYPT), a dynamic biopharmaceutical company, is on a mission to enhance the lives of patients facing serious retinal diseases. Recently, the company made a notable announcement regarding the expansion of its team through the granting of non-statutory stock options to new...

Continue Reading
IonQ Shares: Insights Into Their Current Market Performance

Updated Category News Views 204

Overview of IonQ's Current Stock Performance IonQ Inc. IONQ shares have seen a notable decline recently, continuing a downward trend that’s persisted over the last couple of weeks. As the company gears up to announce its second-quarter earnings, investors are closely monitoring the developments, particularly the anticipated shift in stock momentum. Market Sentiment and...

Continue Reading
Exploring the Promising CD47 Inhibitor Drug Market Growth

Updated Category News Views 40

Understanding the CD47 Inhibitor Drug Market Gaining insights into the CD47 inhibitor drug market is crucial for recognizing the changes and advancements in cancer immunotherapy. These drugs play a vital role in the battle against cancer by harnessing the body's immune system to identify and eliminate malignant cells. CD47's Role in Cancer CD47, often referred to as the...

Continue Reading